University of Wisconsin–Madison

GOG-0262/ACRIN 6695

July 2011 to August 2012

•Imaging Endpoints: -Changes in tumor perfusion parameters- as quantified by vascularity or blood volume (BV); perfusion or blood flow (BF); mean transit time (MTT); and microvascular permeability or permeability surface area product (PS), from T0 to T1, T0 to T2, and T1 to T2.

This project led by: Elizabeth Sadowski MD